Macrocyclic compounds as IRAK1/4 inhibitors and uses thereof
US9708324B2 · kind B2 · utility
7Cited by
0References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 5, 2016 |
| Grant date | Jul 18, 2017 |
| Priority date | — |
| Expiry date | Feb 5, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.